The Novel Compound SIC-19 Triggers CUL4B-Mediated Ubiquitination and Degradation of SIK2

Yeqiu Zou1, Jiaqi Liu1, Shunpeng Zhu1

  • 1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, China.

Insights

SIC-19, a novel small molecule, targets salt-inducible kinase 2 (SIK2) degradation. This mechanism involves CUL4B-DDB1 ligase, offering potential for ovarian cancer targeted therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Small-molecule inhibitors are emerging as potential cancer therapeutics.
  • Previous research identified SIC-19 as a compound inducing salt-inducible kinase 2 (SIK2) degradation, showing promise for ovarian cancer treatment.
  • The precise mechanism by which SIC-19 induces SIK2 ubiquitination remained unclear.

Purpose of the Study:

  • To elucidate the mechanism of SIC-19-induced SIK2 ubiquitination and degradation.
  • To identify the E3 ubiquitin ligase complex responsible for SIK2 ubiquitination.
  • To determine the role of specific SIK2 residues in this degradation pathway.

Main Methods:

  • Mass spectrometry to identify SIK2-interacting ubiquitin ligases.
  • Immunoprecipitation assays to confirm SIK2 and CUL4B-DDB1 interaction.
  • Western blot analysis to assess CUL4B's role in SIK2 ubiquitination and degradation.
  • Site-directed mutagenesis to identify critical SIK2 residues.

Main Results:

  • SIC-19 promotes the interaction between SIK2 and the CUL4B-DDB1 E3 ubiquitin ligase complex.
  • CUL4B is essential for SIC-19-induced SIK2 ubiquitination and subsequent degradation.
  • SIK2 ubiquitination and half-life are dose-dependent on SIC-19 and CUL4B expression.
  • Lysine 144 (K144) in SIK2 was identified as a critical residue for degradation, impacting cancer cell proliferation and migration.

Conclusions:

  • SIC-19 induces SIK2 degradation via a novel CUL4B-dependent ubiquitination pathway.
  • This mechanism highlights SIC-19's potential as a targeted therapeutic agent for cancers driven by SIK2.
  • Targeting SIK2 degradation represents a promising strategy for ovarian cancer therapy.

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...